{
  "name" : "dacemirror.sci-hub.se_journal-article_2abab3d2af436be30eb20b1cee0b8874_havanur2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Poly(N,N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice",
    "authors" : [ "Sushma Havanur", "Inayat Batish", "Sri Pragnya Cheruku", "Karthik Gourishetti", "JagadeeshBabu P.E.a", "Nitesh Kumar" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "Contents lists available at ScienceDirect\nMaterials Science & Engineering C\njournal homepage: www.elsevier.com/locate/msec\nPoly(N,N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice\nSushma Havanura, Inayat Batisha, Sri Pragnya Cherukub, Karthik Gourishettib, JagadeeshBabu P.E.a,⁎, Nitesh Kumarb\na Department of Chemical Engineering, National Institute of Technology Karnataka, Surathkal, Mangalore, Karnataka, India bDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India\nA R T I C L E I N F O\nKeywords: Doxorubicin Drug carrier Graphene quantum dots Melanoma Nanohydrogel Poly(N,N-diethyl acrylamide)\nA B S T R A C T\nCancer has emanated as a daunting menace to human-kind even though medicine, science, and technology has reached its zenith. Subsequent scarcity in the revelation of new drugs, the exigency of salvaging formerly discovered toxic drugs such as doxorubicin has emerged. The invention of drug carrier has made drug delivery imminent which is ascribable to its characteristic traits of specific targeting, effective response to stimuli and biocompatibility. In this paper, the nanoscale polymeric drug carrier poly(N,N-diethyl acrylamide) nanohydrogel has been synthesized by inverse emulsion polymerization. Lower critical solution temperature of the polymeric carrier has been modified using graphene quantum. The particle size of pure nanohydrogel was in the range of 47 to 59.5 nm, and graphene quantum dots incorporated nanohydrogels was in the range of 68.1 to 87.5 nm. Doxorubicin (hydroxyl derivative of anthracycline) release behavior as a function of time and temperature was analyzed, and the Lower critical solution temperature of the synthesized nanohydrogels has been found to be in the range of 28–42 °C. Doxorubicin release characteristics have improved significantly as the surrounding temperature of the release media was increased near to physiological temperature. Further, the cumulative release profile was fitted in the different kinetic model and found to follow a Fickian diffusion release mechanism. The hydrogel was assessed for its cytotoxicity in B16F10 cells by MTT assay. In-vivo studies were done to study the lung metastasis by melanoma cancer and the results showed a rational favorable prognosis which was confirmed by evaluating hematological parameters and the non-immunogenic nature of nanohydrogel by cytokine assay. Comprehensively, the results suggested that poly(N,N-diethyl acrylamide) nanohydrogels have potential application as an intelligent drug carrier for melanoma cancer."
    }, {
      "heading" : "1. Introduction",
      "text" : "Melanoma is the least common type of skin cancer, but it is most lethal. Recent statistics of the World Health Organization has reported that approximately 132,000 new cases of melanoma are diagnosed worldwide each year, especially among western countries, for example, in the United States the percentage of people affected by melanoma has more than doubled in the past 30 years [1,2]. The metastatic stage is the leading health threats in melanoma, particularly lung metastasis is incurable. The prime cause of mortality (about 39%) in lung metastasis is respiratory failure, which is due to the replacement of normal lung tissue by tumor cells [3]. Respiratory failure is generally due to\nresistance to the drug, low targeting efficiency and lack of target selectivity between tumor cells and normal cells [4]. The primary or metastasizing tumor cells that are treated by radiotherapy and chemotherapy have proven to be effective but it has its own limitations. In chemotherapy, the anti-cancer drugs are non-specifically distributed in the human body, affecting both normal cancerous and cells. Non-specific delivery of drugs become toxic to normal cells, tissues, organs and limits the therapeutic dose within cancer cells; and further causes several adverse side effects including hair loss, weakness, and organ dysfunction [5]. Lung metastasis remains as one of the refractory diseases that demands an innovative drug delivery system. Drawbacks mentioned above can be overcome by alternative strategy like\nhttps://doi.org/10.1016/j.msec.2019.110094 Received 24 October 2018; Received in revised form 19 July 2019; Accepted 15 August 2019\n⁎ Corresponding author at: Chemical Engineering Department, National Institute of Technology Karnataka, Srinivasnagar, Surathkal, Mangalore 575025, Karnataka, India.\nE-mail addresses: jagadeesh_78@yahoo.com, dr.jagadeesh@yahoo.co.in (J. P.E.).\nMaterials Science & Engineering C 105 (2019) 110094\nAvailable online 19 August 2019 0928-4931/ © 2019 Elsevier B.V. All rights reserved.\nT\nnanotechnology-based drug delivery systems (NDDs). Kytai (2011) and Torchilin (2014) has classified the NDDs as follows: lipid-based vehicles (micelles, solid lipid nanoparticles, and liposomes), polymeric carriers (hydrogels, polymersomes, dendrimers, and nanofibers), carbon structures (nanodiamonds, nanotubes, graphene, and nanohorns), metallic nanoparticles (gold, silver, and titanium), and inorganic particles (silica) [5,6]. Many NDDs approved by Food and Drug Administration (FDA) and few novel NDDs are currently under development stage due to their advantages like biocompatibility, large surface area, sustained release, better solubility of drugs, drug holding capacity, targeted delivery of drugs, stimulus controlled release of drugs, simultaneous visualization of sites of drug delivery through imaging modalities, and/or real-time feedback on the in-vivo efficacy of a therapeutic agent [7–9]. Due to these advantages, NDDs are commonly used in applications like: materials responsive to specific molecules (antigens or glucose used as biosensors), sustained-release delivery system, bioreactors containing immobilized enzymes, adhesives, coatings, water gel explosives, diapers, medical electrodes, contact lenses, breast implants, recyclable absorbents, bioassay systems, display devices, optical shutters, actuators, valves, chemical memories, sensors, artificial muscles for robotic devices, paints, and molecular separation systems [10].\nAmong the available NDDs, polymeric nanohydrogels have gained enough attention due to their extensive flexibility, simple preparation and effective drug encapsulation (high/low molecular weights, hydrophilic/hydrophobic molecules, and biopharmaceuticals) [11]. Nanohydrogels are 3D polymeric network cross-linked with hydrophilic macro-molecules with a diameter of 1–100 nm [12]. These nanohydrogels have characteristics features of both hydrogels and nanoparticles like hydrophilicity, flexibility, versatility, high water absorptivity and biocompatibility along with all the merits of nanoparticles [13]. Nanohydrogels change their network structure, chemical properties, swelling/deswelling property, and permeability in response to external environmental parameters such as temperature, pH, solvent composition, electric field, and ionic strength and these hydrogels are called as stimuli-responsive nanohydrogels [14,15]. Among the different stimuli-responsive nanohydrogels, thermo-responsive nanohydrogels have received considerable attention due to their faster response to the external temperature and its smaller relaxation time (e.g., fast diffusion process) [13,14]. In melanoma therapy, nanohydrogels can act as an intratumoral chemotherapeutic agent by promoting accumulation or maintenance of high levels of an intracellular chemotherapeutic agent [16]. Thermo-responsive nanohydrogels undergo a volume phase transition along with a change in particle size based on upper or lower critical solution temperature (UCST or LCST) [17]. Different types of polymers are used as temperature sensitive nanohydrogels and among them poly(N,N-diethyl acrylamide) (PDEA) having LCST of 33 °C have been recently researched as a drug carrier [18–21]. The LCST of PDEA could be adjusted by altering the hydrophilic or hydrophobic property of the polymer by adding suitable nanomaterial during its polymerization reaction. Researchers have tried to change the LCST of PDEA (Table 1 [21–26]) using different monomers like DMAAm, NVP [27] and clay particles [28], but they could not retain or improve mechanical strength, release characteristics, in vitro, and invivo biocompatibility of native PDEA. Table 2 shows the advantages and disadvantages of different nanosystem used as drug delivery carriers [29]. Graphene sheets with lateral dimensions< 100 nm in few layers (< 10 layers) form a novel group of molecules called graphene quantum dots (GQDs) [30,31]. GQDs can be used in drug delivery system due to the presence of various functional groups like carboxyl, hydroxyl, carbonyl, and epoxy groups and also has significant delocalized π electrons [32]. GQDs emerged as superior and universal fluorophores because of their unique physical and chemical properties, including small size, chemical inertness, stable photoluminescence (PL), low cytotoxicity, and excellent biocompatibility [33,34]. Due to their stable PL and low cytotoxicity, GQDs could be utilized as suitable alternatives in bio-imaging and optical sensing [35]. Due to its small size Ta bl e 1 PD EA na no /m ic ro hy dr og el s sy nt he si s an d th ei r ap pl ic at io ns . Po ly m er Po ly m er iz at io n LC ST\n(° C ) an\nd si ze\nA pp\nlic at io n\nR ef er en\nce\nC hi to sa n co\nat ed\npe ct in -g ra ft -p ol y( N ,N -d ie th yl\nac ry la m id e)\nM ic ro w av\nein du\nce d fr ee\nra di ca l co\npo ly m er iz at io n\n30 –3\n2 an\nd 78\n6 ± 61 (μ m )\nC on\ntr ol le d dr ug\nde liv\ner y\n[2 2]\nPo ly (N\n,N -d ie th yl\nac ry la m id e)\ngr af te d al gi na\nte M ic ro w av\neas si st ed\nfr ee\nra di ca l co\npo ly m er iz at io n\n27 –2\n8 an\nd 71\n0 ±\n0. 07\n(μ m )\nC on\ntr ol le d dr ug\nde liv\ner y\n[2 3]\nC ar bo\nxy la te d m ul ti -w\nal le d ca rb on\nna no\ntu be\ns/ po\nly (N\n,N -d ie th yl ac ry la m id e)\nR ad\nic al\npo ly m er iz at io n\n– El ec tr oa\nct iv e dr ug\nm ol ec ul ar\npr ob\nes in\nel ec tr oc\nhe m ic al\nbi os en\nso rs\n[2 4]\nH yd\nro ph\nili c ba\nck bo\nne of\npo ly (a cr yl ic ac id -c o2- ac ry la m id o2- m et hy\nlp ro pa\nne ) su lf on\nic ac id\nw it h si de\nch ai n po\nly (N\n,N -d ie th yl ac ry la m id eco -N\n,N -d im\net hy\nla cr yl am\nid e)\nFr ee\nra di ca l co\npo ly m er iz at io n an\nd gr af ti ng\non to\nte ch\nni qu\ne in\naq ue\nou s so lu ti on\n31 .7 –5\n2. 4 an d 20 0– 40 0 nm\nTh er m ot hi ck en\nin g ag\nen t\n[2 5]\nPo ly (N\n-i so pr op\nyl ac ry la m id eco -a cr yl ic\nac id -c oN ,N -d ie th yl ac ry la m id e)\nFr ee\nra di ca l po\nly m er iz at io n\n23 –3\n3 an\nd 10\n0– 20\n0 nm\nFo od\npa ck ag\ne [2 6]\nG ra ph\nen e qu\nan tu m\ndo ts\nin co\nrp or at ed\npo ly (N\n,N -d ie th yl ac ry la m id e)\nIn ve\nrs e em\nul si on\npo ly m er iz at io n\n28 –4\n2 an\nd 47\n–9 9 nm\nD ru g de\nliv er y\nIn th is\nw or k\nand its biocompatibility, GQDs could also serve as active carriers for drug delivery while simultaneously monitoring the release of the drug, to enhance the chemotherapeutic efficiency of anticancer drugs and can improve the performance of drug carrier [36]. Compared to other nano materials, GQD has many desired properties and GQD can be synthesized easily using top down approach at cheaper cost.\nIn this study, we prepared thermo-responsive nanohydrogel using inverse emulsion polymerization method as nano drug carrier to carry doxorubicin. GQDs were produced using a simple bottom-up approach by pyrolysis of citric acid, and the synthesized GQDs were used in nanohydrogel to increase the LCST and anticancer properties of the gels. Morphology of synthesized nanohydrogel was analyzed using TEM, DLS, FTIR, TGA, and GPC. Time and temperature release behavior of the nanohydrogels was studied. Mathematical modeling was done to illustrate the factors influencing the release behavior of the nanohydrogels. Cytotoxicity of nanohydrogels was performed on B16F10 melanoma cancer cell lines. Murine melanoma model was developed by intravenous injection (via tail vein) of B16F10 cell lines in C57BL/6 mice. Efficacy of doxorubicin (DOX) loaded nanohydrogels for the treatment of lung metastasis was preliminarily studied by measuring the body weight, organ weight, and lung metastatic counts. Additionally, hematology and cytokine assays were conducted to evaluate potential toxicity, immunogenicity of DOX-loaded nanohydrogels with prognosis. Histopathology was performed to confirm the presence of tumor that might not be evident by visual confirmation."
    }, {
      "heading" : "2. Materials and methods",
      "text" : "Citric acid (CA, 99%) was purchased from Molychem, Thane, India. L-Leucine (Leu, 99%) and L-Methionine (Met, 99%) was purchased from Sisco Research Laboratories Pvt. Ltd. (SRL), Mumbai, India. N,Ndiethyl acrylamide (DEA, 98%) was procured from Tokyo Chemical Industry Co., Ltd. (TCI), Tokyo, Japan. Ammonium peroxodisulfate (APS, 98%), was purchased from Merck Specialities Pvt. Ltd., Mumbai, India. N,N′-methyl bisacrylamide (MBA, 99%) was procured from Loba Chemie, Mumbai, India. N,N,N′,N′-tetramethylethylenediamine (TEMED, 99%) was procured from HiMedia Laboratories Pvt. Ltd., Mumbai, India. From Sigma-Aldrich, Span 80 (SP, 95%), Cyclohexane (CY, 99.5%) and Doxorubicin Hydrochloride Pharmaceutical secondary standard (DOX) were procured. For all the experiments Milli-Q water was used."
    }, {
      "heading" : "2.1. Synthesis of graphene quantum dots (GQDs)",
      "text" : "GQDs were synthesized by microwave-assisted pyrolysis of CA [15]. In a typical procedure, 5 g of CA was weighed and powdered using mortar and piston. The obtained powder was placed in a preheated domestic microwave (Onida, Model: 20 Solo Dlx) at 700W. During pyrolysis, CA was liquidated and the color of the liquid changed from colorless to dark brown. Further, the dark brown product was dissolved in 1mol L−1 of NaOH solution and preserved at 4 °C for further\ncharacterization and use. Further, the same procedure was followed to functionalize the GQDs by the addition of amino acids (leucine and methionine)."
    }, {
      "heading" : "2.2. Synthesis of PDEA nanohydrogel",
      "text" : "Nanohydrogels (N – Bare PDEA, NG – GQDs incorporated PDEA, NL – Leucine functionalized GQDs incorporated PDEA, and NM - – Methionine functionalized GQDs incorporated PDEA) were synthesized by inverse emulsion polymerization (IEP) technique. The monomer DEA (8.717mmol), cross-linker MBA (129.7 μmol), initiator APS (87.67 μmol) were dissolved in 5mL of milli-Q water at ambient temperature (28 °C) and transferred to a three-necked round-bottom flask containing CY with span 80 a non-ionic surfactant which has hydrophilic-hydrophobic balance (HLB) value of 4.3. The mixture was homogenized at 10,000 rpm for 1 h to produce nanospheres at room temperature. Homogenization emulsified the water phase into the continuous organic phase and produced nanospheres. Then the mixture was stirred continuously with magnetic stirrer and the polymerization reaction was initiated by adding 50 μL of TEMED. The reaction was continued for 6 h under nitrogen atmosphere. After the completion of the reaction, the products were allowed to settle, and centrifugally washed repeatedly using pure CY to remove the surfactant. The product was then re-dispersed in deionized water and subjected to repeat centrifugal washing. During washing, the nanohydrogel particles were centrifuged at 12,000 rpm for 30min using milli-Q water to remove span 80 and un-reacted chemicals. Then the particles were lyophilized to produce free flow powder and stored for further studies. Similar protocol was used to synthesize NG, NL, NM by using 0.075 g bare GQDs, leucine functionalized GQDs and methionine functionalized GQDs."
    }, {
      "heading" : "2.3. Characterization of synthesized GQDs and nanohydrogels",
      "text" : "The particle size of graphene quantum dots and nanohydrogels were measured using Horiba Scientific nano Partica, nanoparticle size analyzer, SZ-100.Fluorescence spectra were obtained by using Fluorescence spectrophotometer (Horiba, JY, Fluoromax-4). UV–vis absorption was carried out using a UV–Vis/NIR spectrophotometer (HITACHI, U-2900 UV–vis Spectrophotometry). FTIR analysis (Bruker) was performed between 500 cm−1 and 4000 cm−1 to analyze the functional groups. The weight change in the lyophilized hydrogel was measured using thermogravimetric differential thermal analyzer (Exstar, 6000 TG-DTA 6300) under nitrogen atmosphere at a flow rate of 50mL/min. The temperature was raised from room temperature to 700 °C using a linear programmer at a heating rate of 10 °C/min. Elemental analysis was carried out using Elementar Vario EL III. To prepare a sample for TEM measurement, an aqueous solution of prepared GQDs and the polymer (0.01mg/mL) was stirred for 24 h at room temperature to reach thermodynamic equilibrium. A drop of a polymer solution was then deposited onto a 200-mesh carbon coated copper grid\nand dried overnight in a desiccator. The TEM analysis was performed in JOEL (Model: JEM 2100) at an acceleration voltage of 200 kV using a LaB6 source. Gel permeation chromatography (GPC) was performed using Perkin Elmer (Model: Turbo matrix - 40) equipped with PLgel Mixed-D column (dimension: 300mm length, 7.5mm internal diameter and 5 μm particle size; molecular weight range 2590–275,000) in THF. The number average molecular weight (Mn) and polydispersity index (Mw/Mn) of the synthesized polymers was determined by a polystyrene calibration."
    }, {
      "heading" : "2.4. In-vitro drug loading and release studies of PDEA nanohydrogel",
      "text" : "The applicability of synthesized nanohydrogels in controlled release of the drug was studied by subjecting the gels to drug loading and drug release studies using DOX as a model drug. A calibration curve was developed for the known concentration of DOX at 480 nm using UV–Vis spectroscopy (HITACHI, U-2900 UV–vis Spectrophotometry). In the case of nanohydrogels, known weight of dried gels was placed in 10mL of loading solution (30 ppm of DOX solution) to equilibrate for 48 h at room temperature. Then the gels were removed from the loading solution and rinsed with water. The DOX content in the nanohydrogels was determined by measuring the concentration of DOX in the loading solution before and after loading, using UV–Vis/NIR spectrophotometer at 480 nm. The loading capacity and entrapment efficiency of the nanohydrogels were calculated using Eqs. (1) and (2) respectively.\nLoading capacity\n= × M M (%μg/mL) 100DN N (1)\nEncapsulation efficiency\n= − × M M\nM (%W/W) 100DI DSP\nDI (2)\nwhere, MDSP is the mass of drug present after drug loading, MDI is the initial mass of drug present in the solution, MN is the initial mass of the gel and MDN is the mass of drug encapsulated within the gels (MDN=MDI−MDSP).\nThe release profile of the nanohydrogel at a temperature below and above LCST was examined. The drug release experiments were performed at three different temperatures i.e., 30 °C, 37 °C and 40 °C. Accurately weighed DOX encapsulated gels were suspended in 10mL of PBS buffer. At a regular time interval, 1 mL of solution was withdrawn and analyzed using UV–Vis spectrophotometer to determine the amount of DOX released. The withdrawn solution was replaced back to maintain the original volume in the beaker. The release results were presented as cumulative release as a function of time, which is calculated as per the Eq. (3);\nCumulative released\n= ×\n∞\nD D (%) 100t (3)\nwhere, Dt is the concentration of DOX released from the gels at time t and D∞ is the estimated concentration of DOX-loaded in the gels.\nFurther, the temperature response of the nanohydrogel between the temperatures from 20 °C to 60 °C was studied using the above mentioned protocol."
    }, {
      "heading" : "2.5. Analysis of drug release pattern from nanohydrogels",
      "text" : "The solute release from the cross-linked structure is based on the swelling behavior of the polymers and rate of diffusion. To deduce the release mechanism, drug release from the cross-linked networks of PDEA nanohydrogels has been analyzed using zero-order, first-order,\nHiguchi, Korsmeyer-Peppas and Hixon-Crowel models. Following equations are the model equations used to analyze drug release mechanism [37,38].\nZero-order kinetic model:\n= −C C K tt o o (4)\nwhere, Ko is the zero-order rate constant, Co is the initial concentration of drug (at t= 0) and Ct is the amount of drug released at time t\nFirst-order kinetic model:\n= −log C log C K t/2.303o 1 (5)\nwhere, K1 is the first-order rate constant, Co is the initial concentration of drug (at t= 0) and Ct is the amount of drug released at time t.\nHiguchi model:\n=Q K t2 1/2 (6)\nwhere, Q is the cumulative release of drug in time t and K2 is the Higuchi constant.\nKorsmeyer-Peppas model:\n=\n∞\nM M K tt 3 n (7)\nwhere, K3 is the release rate constant, ∞ M M t is the fraction of drug release at time t and n is the release exponent.\nHixon-Crowel model:\n− =W W K to1/3 t1/3 4 (8)\nwhere, K4 is the Hixon-Crowel constant, Wt is the remaining amount of drug in the gel at time t and Wo is the initial amount of drug in gel."
    }, {
      "heading" : "2.6. Degradation of nanohydrogels",
      "text" : "The synthesized nanohydrogels (0.1 g) were immersed in 10mL of phosphate buffered saline (PBS: 1×, 7.4 pH) and incubated at 37 °C. At a specific time interval, the mass of dry gel (dried using lyophilization) was measured until the constant value was obtained. Degradation of nanohydrogel was estimated by measuring the residual weight as follows:\n= − ×Degradation (%) (W W) W 100o t t (9)\nwhere, Wt is the mass of undegraded dry nanohydrogel and Wo is the initial mass of dry nanohydrogel."
    }, {
      "heading" : "2.7. Cell lines and media used for culturing",
      "text" : "The murine melanoma cell lines (B16F10) were purchased from National Centre for Cell Science (NCCS), Pune, Maharashtra, India. The cells were cultured in Dulbecco's modified Eagle medium (DMEM, Sigma, Saint Louis, MO, USA) with 10% fetal bovine serum (Hyclone, Logan, UT, USA) and 1% of penicillin-streptomycin (Himedia, India). The quintessential growth of cells was attained using ambient conditions of 37 °C and 5% CO2 for humidity."
    }, {
      "heading" : "2.8. Biocompatibility studies of nanohydrogels",
      "text" : "The cytotoxicity of the nanohydrogels (PDEA and GQDs incorporated PDEA) was evaluated by performing 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The nanohydrogel samples were sterilized and exposed to the Dulbecco's modified eagle's medium (DMEM) for 16 h. After sufficient exposure, the supernatant\nwas filtered through a syringe filter to remove undissolved nanohydrogel debris and the filtrate was used as the test sample. For the cytotoxicity test, exponentially growing B16F10 cells were harvested and the cell count was adjusted to 10,000 cells/mL of the medium. 100 μL of this suspension was seeded to each well of a 96 well plate. The plate was incubated at 37 °C in an atmosphere consisting of 5% CO2 for 24 h for cell adhesion. After 24 h, the medium was replaced with different concentration of the test samples. Cells were further incubated for a period of 48 h in the same conditions. After the incubation, the medium in each well was replaced with 50 μL of MTT reagent (2 mg/mL MTT reagent in PBS buffer). The cells were incubated for another 4 h at 37 °C in dark. On completion of incubation, the MTT reagent was removed and the formed formazan crystals were dissolved in 100 μL dimethyl sulfoxide (DMSO) solution. The optical density (OD) was measured at 540 nm with a microplate reader. The cell viability rate was calculated using Eq. (10).\n= × OD OD Viability (%) 100treated Control (10)\nwhere, ODtreated is the optical density obtained in the presence of nanohydrogel and ODcontrol is the optical density obtained in the absence of nanohydrogel."
    }, {
      "heading" : "2.9. Animals, murine melanoma model and in-vivo studies",
      "text" : "The mice (C57BL/6) aged 8–10weeks with a weight of 18–30 g were procured from central animal research facility of Manipal Acadamy of Higher Education, Manipal, Karnataka, India. All the animals were transferred to polypropylene cages and placed in ambient housing conditions of 23 ± 2 °C temperature and 50 ± 5% atmospheric moisture. Aseptic food and water were provided ad libitum. Mandating process of experimental procedure was done by the Institutional Animals Ethics Committee (94/PO/ReBi/S/1999/ CPCSEA) and experimentation was done following the specification approved by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA).\nThe mice were separated into seven groups with n number of mice (n=4/group) in each group, to study the anti-tumor effect of the nanohydrogels. The melanoma model was established by injecting 0.1 mL of B16F10 cell having a cell count of approximately 106 cells via intravenous route (tail vein) for six groups, and one group was injected with PBS buffer as normal control. After the development of melanoma, the anti-cancerous activity of drug loaded nanohydrogels (N-bare PDEA nanohydrogel; NG-bare GQDs grafted PDEA nanohydrogel; NL-leucine functionalized GQDs grafted PDEA nanohydrogel and NM-methionine functionalized GQDs grafted PDEA nanohydrogel) were tested. Injected nanohydrogel concentration was established according to their encapsulation efficiency as reported in the literature [39,40], homologous to 2.5 mg/kg of DOX. Groups were entitled and classified as follows:\nGroup I: Normal control. Injected PBS buffer as vehicle. Group II: Diseased control. Injected with B16F10 cell lines and PBS buffer as vehicle. Group III: DOX control. Injected with cell lines and treated with standard DOX. Group IV: N. Injected with cell lines and treated with N loaded-DOX. Group V: NG. Injected with cell lines and treated with NG loadedDOX. Group VI: NL. Injected with cell lines and treated with NL loadedDOX. Group VII: NM. Injected with cell lines and treated with NM loadedDOX.\nMice were humanely euthanized, after four weeks of treatment and used for further studies. Mice weights were noted throughout the experiments and after euthanization, all the organs were excised and their\nrespective weight was recorded. The organ weight index was calculated using Eq. (11),\n= ×Organ weight index Organ weight\nBody weight before euthaniztion 100\n(11)"
    }, {
      "heading" : "2.10. Hematological parameters and tumor count evaluation",
      "text" : "The blood sample was collected from the retro-orbital plexus of animals in Eppendorf tubes containing EDTA as an anticoagulant and further analyzed using a veterinary blood cell counter (KE-210 VET. ERMA Inc. Tokyo. Japan). Metastatic spots present on excised lung were counted manually."
    }, {
      "heading" : "2.11. Analysis of TNF-α and IL-6",
      "text" : "Plasma was collected from blood by centrifugation at 8000 rpm for 10min in tubes with EDTA as an anticoagulant. For TNF-α analysis, mouse ELISA kit (catalogue number - KMC3011) of thermo-fisher scientific was used. Also, for IL-6 analysis, Quantikine® ELISA kit (catalogue number - M6000B) of R & D systems was utilized. Standard curve and sample analysis were conducted following manufactures instructions. Assays were done in duplicates for accuracy."
    }, {
      "heading" : "2.12. Statistical analysis",
      "text" : "The animal study experiments were statistically analyzed using ANOVA for significant differences. All the data were compared with normal and disease control. Indication of significance was done by *P < 0.05 (significant) w.r.t normal control, **P < 0.01 (highly significant), ***P < 0.05 (significant), and ****P < 0.05 (highly significant) w.r.t disease control also, aP < 0.05 and bP < 0.01 compared with doxorubicin."
    }, {
      "heading" : "3. Results and discussion",
      "text" : ""
    }, {
      "heading" : "3.1. Synthesis and functionalization of GQDs",
      "text" : "GQDs were prepared by microwave assisted pyrolysis of CA (Scheme 1) which is a simple, efficient and eco-friendly bottom-up approach. At the end of microwave pyrolysis, a light-yellow colored solution with blue emission under UV light (365 nm) was observed after adjusting the pH of the solution to 7 using NaOH. CA molecules selfassembled into thin sheet-like structure followed by condensation reactions through intermolecular dehydroxylation, forming nanocrystalline GQDs with functional groups like-OH, -CH2-, -COOH, -COOR on its surface [41,42]. In this study, GQDs were synthesized along with amino-acids (Leu and Met) to functionalize GQDs. CA was used as carbon source, Leu and Met were used as -NH2 source. During the synthesis process, the –NH2 group of Leu and Met reacts with carboxyl or hydroxyl groups of the GQDs to form leucine functionalized GQDs and methionine functionalized GQDs [43].\nThe UV–vis absorption spectra and photoluminescence spectra of prepared bare GQDs, leucine functionalized GQDs and methionine functionalized GQDs are shown in Fig. 1. The synthesized graphene quantum dots (Fig. 1a) showed a well-defined broad absorption peak at 230 nm and another peak between 365 and 400 nm where the peaks ascribed to π-π⁎ electron transition of the conjugated C]C bond and nπ⁎ electron transition of the C]O bond, which resulted in a strong fluorescence [44–46]. The PL spectra in Fig. 1b were recorded at 365 nm, and the bare GQDs shows a sharp peak at 450 nm, leucine functionalized GQDs at 457 nm and methionine functionalized GQDs at 490 nm [46]. Functionalization of bare GQDs showed significant spectral shift due to the difference in the particle size and emission sites of the functionalized GQDs and the similar phenomenon were reported in\nthe literature for carbon-based quantum dots [47,48]. The particle size of bare GQDs was in the range of 0.7 nm–2.5 nm, the size of leucine functionalized GQDs was in the range of 12.8 nm–70.6 nm and the size of methionine functionalized GQDs was in the range of 27.8 nm–98.9 nm. In this study, the enhanced PL was attributed to the formation of pyrrolic-N in GQDs, which substituted the –COOH functional groups at the edges of GQDs and also the relatively strong electron affinity of pyrrolic-N rings in the leucine functionalized GQDs and methionine functionalized GQDs [49].\nThe absolute quantum yield of bare GQDs, leucine functionalized\nGQDs and methionine functionalized GQDs was measured using quinine bisulfate (0.1M in H2SO4 as a standard sample) at 365 nm excitation. The quantum yield of the prepared bare GQDs was 18.75%, whereas leucine functionalized GQDs showed a quantum yield of 20.26% and methionine functionalized GQDs showed a quantum yield of 16.82%. Difference in the quantum yield could be ascribed to the presence of immense number of carbonyl group, which indicate the incomplete pyrolysis of CA and also the presence of a large number of carboxylic groups leads to formation of surface defects which was further confirmed in FTIR (Supporting material) [50–52]. Since the bare\nScheme 1. Possible scheme of reaction for bare GQDs (GQDs), leucine functionalized GQDs (Leu-GQDs) and methionine functionalized GQDs (Met-GQDs) synthesis.\nGQDs, leucine functionalized GQDs and methionine functionalized GQDs contain epoxy and carboxylic groups on their surface it acted as non-radiative electron-hole recombination centre [53]."
    }, {
      "heading" : "3.2. Synthesis of PDEA nanohydrogels and morphological analysis",
      "text" : "The PDEA nanohydrogels were synthesized by using IEP method with 1:5 water to oil (W/O) ratio (Scheme 2). Stable W/O emulsion was formed by dispersing monomer droplets along with surfactant in a continuous oil phase (cyclohexane) at a high shear force using homogenizer/magnetic stirrer. In the stable W/O emulsion, the dispersed phase consists of DEA, MBA, APS/TEMED and the continuous phase consisted of non-ionic oil-soluble surfactant (3% span 80) and oil (25mL cyclohexane). The reaction was carried at 600 rpm on a magnetic stirrer under N2 atmosphere. After the formation of the emulsion, TEMED was added to initiate the polymerization at room temperature. Nanohydrogels thus formed were washed by repeated centrifugation and then lyophilized for further study.\nThe particle size distribution of prepared nanohydrogels are shown in Table 3, and from the table it could be observed that the particle size varied significantly which could be due to a premature termination of particle growth, which is caused by the presence of the oxygen in the reaction mixture [54]. The molecular weight (Mw) of the synthesized nanohydrogels was determined by GPC using THF as eluent and polystyrene as standard as shown in Table 3. The Mw has increased due to the incorporation of bare GQDs and functionalized GQDs in PDEA nanohydrogels and the polydispersities of the synthesized nanohydrogels were in the range of 1.381 to 1.557.\nFurther, the TEM results are shown in Fig. 2. The synthesized graphene quantum dots (Fig. 2(a–c)) were spherical and their size was in the range of 14–16 nm for bare GQDs, 11–54 nm for leucine functionalized GQDs and 34–67 nm for methionine functionalized GQDs. Due to the functionalization of bare GQDs, the average diameter of the particles increased and also showed agglomeration. The morphology of the nanohydrogels synthesized by IEP shows nearly spherical shape\nwith a wide size range as shown in Fig. 2(d–g). The size of the nanohydrogels was in the range of 3.56 nm–12.88 nm for N, 6.89 nm–19.99 nm for NG, 11.56 nm–24.53 nm for NL and for NM it was 81.11 nm. The size range of synthesized particles observed by TEM was completely different from DLS measurement, and it could be due to the lyophilization effect. Further, the irradiation of electron beam under reduced pressure may swell or shrink, and also the surface tension causes the agglomeration of particles [54]."
    }, {
      "heading" : "3.3. Studies on nanohydrogels degradation",
      "text" : "Degradation studies were done over a period of 11 weeks, and immutability of degradation attained was used as a sole factor for termination of the experiment as shown in Fig. 3. The sample N showed a maximum degradation of 84.95%. Constant degradation rate was observed from 8th week, and also showed a sudden exponential degradation from 3rd week. Maximum degradation was observed between 3rd and 7th week after which stability was achieved. NG showed persistent degradation pattern in contrast to N. The NG showed a sudden spike in the degradation from 1st to 3rd week. Succeeding 3rd week, a steady increment was contemplated till 8th week followed by the regular pattern of degradation. Maximal degradation venerated to N was also reduced and noted to be 68.17% for NG. Degradation could be ascribed to the presence of hydrolytic groups like ester, amine which break down easily by water [55]. Supposedly, the difference in degradation could be accredited to the presence of hydrophilic moieties in NG, the formation of hydrogen bond between water and GQDs provides stability and thus, degradation becomes arduous. An assumable difference in degradation profiles of NG and NL/M could be due to propinquity of hydrophobic factions, i.e., leucine and methionine."
    }, {
      "heading" : "3.4. Doxorubicin loading and in-vitro release behaviour from nanohydrogels",
      "text" : "The loading capacity (LC) and encapsulation efficiency (EE) of all the four polymers were recorded as shown in Table 4. It was observed that there is a distinct decrease in EE and LC as graphene quantum dots grafted in nanohydrogels. There was two-fold declination in LC after functionalization, and this decline was associated with the increase in molecular weight of polymers as moieties of graphene quantum dots were grafted in PDEA nanohydrogels. This could be explained by a nonanalogous dispensation of the drug inside a nanohydrogel structure [56].\nThe response of nanohydrogels was studied at different temperatures to know the LCST of the nanohydrogels as shown in Fig. 4a. It was observed from the figure that there is a notable change in release rate\nScheme 2. Synthesis of PDEA nanohydrogels by inverse emulsion polymerization.\nwith respect to change in temperature. It was observed that above LCST, the response of hydrogel was strong compared to the response below LCST. The hydrophilic-nature of hydrogel could be the reason for poor response rate below LCST [57]. The LCST should be close to physiological body temperature (37 °C) to make PDEA as a suitable drug delivery system. GQDs has laid the foundation for an exceptional drug carrier due to the presence of various functional groups like carboxyl, hydroxyl, carbonyl and epoxy groups and presence of significant delocalized π electrons. Presence of more active groups on the surface of GQDs make it hydrophilic and its unique structural properties have shown to influence factors like increase in LCST of PDEA, improve structural stability, biocompatibility, improve drug release efficacy and chemotherapeutic efficacy. Further, release rate of the loaded-drug has increased with increase in surrounding temperature.\nThe effect of drug release from polymeric particles was observed concerning the time at three different temperatures, i.e., at 30 °C, 37 °C\nand 40 °C (Fig. 4(b–d)). The cumulative release of DOX (30 ppm) from nanohydrogel samples N, NG, NL and NM was analyzed at physiological pH of 7.4 in PBS buffer by mimicking the body pH and elevated body temperatures attained during diseased conditions. Maximum release observed at 40 °C for all the nanohydrogels were N-85.98%, NG86.35%, NL-80.12% and NM-58.78% as shown in Fig. 4c. Increase in release at elevated temperature was due to change in LCST that causes the reversible phase transition. Below LCST, the polymer is hydrated but once LCST is exceeded, polymeric chains disintegrate and aggregate abruptly and thus, nanohydrogel shrinks drastically [58]. The sample N exhibited a controlled release up to 120min at 40 °C, then attained a plateau presenting a steady release. Incorporation of GQDs showed a clear difference in release profile of NG and it manifested a slower and controlled release expanding over a period of 480min, also slightly higher than N. This phenomenon can be attributed to the incorporation of hydrophilic GQDs moieties [59,60]. GQDs could be able to prevent\nmesoporous leaking of DOX from nanohydrogel by lowering the rate of release. Higher temperature (40 °C) can weaken the chemical bond strength between the polymeric matrix and GQDs resulting in its dissociation and accelerating DOX release [61]. Dissociation of GQDs is beneficial as it possesses anticancer properties and is also able to enhance the activity of DOX [62,63]. Functionalized GQDs with leucine (NL) had a similar effect on the release profile of nanohydrogels as NG, although GQDs with methionine (NM) did not show a satisfactory release profile. NM showed a burst DOX release in 30min and remained relaxed throughout the rest of the experiment. The reason for these phenomena is the hydrophobic nature of methionine that lowers the LCST of nanohydrogel favoring non-uniform burst release profile [64].\nFurther, at 37 °C as shown in Fig. 4b, the release of DOX from nanohydrogels was inferior as compared to 40 °C, i.e., 65.40% for N, 68.16% for NG, 64.47% for NL and 54.94% for NM. The N showed an upsurge release and became steady after 150min, whereas NG and NL showed a more controlled elevated release up to 250min and 300min respectively. An abrupt and non-significant release of DOX was observed in NM, in contrast to 40 °C. Release studies at 30 °C exhibited a reduction of release as compared to 37 °C and 40 °C, as shown in Fig. 6b. The release profile of nanohydrogels had the maximum release of 62.81% for N, 49.60% for NG, 51.34% for NL and 51.52% for NM. The NG, NL and NM showed a controlled and uniform release than N due to the change in their LCST [59]. As the experiment progressed, the release profiles were accompanied by absorption and desorption of the drug, which was due to re-absorption of DOX and induced precipitation in PBS buffer and degradation of free DOX via hydrolysis [65]. These outcomes were further confirmed with mathematical modeling.\nTable 4 Percentage of DOX encapsulation and loading into nanohydrogels.\nSample ID Encapsulation efficiency (EE) (%) Loading capacity (LC) (%) LCST (°C)\nN 85.873 0.2577 28–30 NG 41.220 0.1237 36–38 NL 41.692 0.1251 40–42 NM 47.350 0.1421 32–34"
    }, {
      "heading" : "3.5. Melanoma tumor model and its treatment",
      "text" : "The melanoma cells were inoculated in the mice through intravenous injection, and the appearance of the tumor was observed after 7th day as illustrated in Fig. 5. On the 7th day, black colored tumors were observed near the tail region, which confirmed the presence of melanoma. The treatment for tumor was performed by administering DOX-loaded nanohydrogels via the intraperitoneal route. The fixed therapeutic dosage was injected once a week for up to four weeks."
    }, {
      "heading" : "3.6. Therapeutic effect on change in body weight, organ weight, and tumor count",
      "text" : "The body weight of the mice was assessed regularly before injecting the weekly booster dose (Fig. 6a), for evaluation of systemic toxicity. In the normal control group injected with PBS showed periodic weight gain, whereas, other groups experienced non-periodic weight gain and loss of weight. Mice injected with DOX experienced weight due to cachexia. Similarly, N loaded with DOX showed loss, but recovered at the end of the experiment. Other groups did not manifest any difference w.r.t to normal and disease groups. There were no eloquent changes recorded overall; thus body weight was considered as a non-significant factor in treatment groups. However, disease group showed the melanoma-related symptom.\nAfter the mice were euthanized on the 29th day, all organs were removed and weighed (Fig. 6b) as it may indicate some toxic effect. DOX group showed significant hepatomegaly, but effect of DOX was reduced by the DOX-loaded nanohydrogels [66]. Disease group had shown significant hepatomegaly and splenomegaly. Splenomegaly as the hallmark of melanoma had been reported in literature [67]. As the largest immune organ, the spleen plays a cardinal role in the recirculation of lymphocytes. Enlarging of the spleen can be explicated to confinement of T lymphocytes in the spleen during lymphocyte recirculation [68]. Therapeutic dose injected groups (group III-VII) displayed a considerable decrease in spleen weight w.r.t disease group, thus effectively curing splenomegaly. Although a decrease in kidney weight was still persistent, this dissentious result was not treated in any group.\nThe maximum reduction in tumor count was observed in DOX\ninjected mice, as shown in Fig. 6c. A pronounced reduction of tumor count was observed in DOX-loaded N and NG groups in analogy with the disease group [69]. However, DOX-loaded NL and NM were unable to subdue the metastatic effect of cancer, probably because of increased LCST value and erratic release profile. There was no significant difference in tumor count of drug present in free or entrapped state. Thus, it deduced an interesting fact that neither of the nanohydrogels altered DOX chemically or physically, indeed allowed effortless release with induction of stimuli. It was comprehended that nanohydrogels were exemplary and faultless drug carriers."
    }, {
      "heading" : "3.7. Evaluation of hematological parameters",
      "text" : "The hematological framework is contemplated as a principle indicator of cancer development and prognostic factor for the positive or negative outcome [70]. Fig. 7 shows the effect of cancer on blood parameters. Diseased group showed notable lymphopenia (Fig. 7a), thrombocytopenia (Fig. 7e) and anemic conditions were observed by red blood cell (Fig. 7b), hemoglobin (Fig. 7c), hematocrit (Fig. 7d). The above anomalies demonstrate poorer prognosis in diseased group which was administered with PBS buffer alone [71]. Foundation of lymphopenia in melanoma is not well illuminated, but one of the reasons could be uninterrupted apoptosis of T lymphocyte caused by tumors [61]. The anemic disorder can be attributed to many factors, like insufficiency of iron, hemolysis, damaged erythropoiesis, tumor cell annexation in erythropoietic environment and initiation of clotting torrent [71]. Imputation of thrombocytopenia (Fig. 7e) can be associated with melanoma as tumor cells can trigger and agglomerate platelets that aggravate metastatic aptitude. Stimulation of platelets facilitates cell attachment, multiplication and chemotaxins, in turn promote tumorigenesis [72].\nEffect of DOX on hematological parameters was identified in group III and it showed leukopenia. Leukopenia is a biological measurement of drug activity associated with the hematologic toxicity caused by drugs to predict the efficiency of treatment [73]. The above parameter was observed by a significant reduction in white blood cells (Fig. 7f). Anemic conditions depicted by the disease model were recovered, but it is significantly different than normal (PBS injected) conditions, similar results were observed in the literature [74].\nNanohydrogel (N) loaded DOX-treated group IV exhibited\nsignificant monocytopenia (Fig. 7h) and recovered from anemia, but recovery was less than the normal control group. The condition of monocytopenia and differentiation of myeloid progenitors was reduced which signifies an improvement in tumor conditions, and additionally it is a positive prognostic factor [70]. NG nanohydrogels loaded DOX (group V) revealed monocytopenia (Fig. 7h). Rehabilitation of anemic conditions was similar to DOX and N loaded DOX nanohydrogels (group IV). NL nanohydrogels loaded DOX (group VI) showed only monocytopenia (Fig. 7h), and anemic condition was not recovered. Hematological parameters were distinguishable as compared to disease group but dissimilar to the normal group. NM group dispensed granulocytopenia (Fig. 7g), monocytopenia (Fig. 7h) and rose in the number of hemoglobin (Fig. 7c) w.r.t disease group, all conditions favoring better survival rate [70]. All nanohydrogels showed a better prognosis factor, i.e. monocytopenia as compared to doxorubicin thus stating a refined anti-tumor activity. Also, showed a positive effect in one or the other aspect, but none of the treatments were able to recover from anemia."
    }, {
      "heading" : "3.8. Evaluation of cytokines level: TNF-α and IL-6",
      "text" : "Cytokines have an integral role in tumor induction and progression. They can facilitate the generation and maintenance of robust antitumor immune responses, but they can also contribute to chronic inflammation and promote tumor formation, growth and metastasis [75]. Among several inflammatory mediators, TNF-α and IL-6 were studied to know the antitumoral effect by nanohydrogels as shown in Fig. 8(a–b). Levels of both TNF- α and IL-6 cytokine can confirm the biocompatibility and immunogenicity of nanohydrogels.\nFrom the assay of TNF-α (Fig. 8a), no significant difference was observed in disease and DOX-treated group with normal control. The\ndifference in TNF-α levels in normal and disease control could be attributed to the better production of immunosuppressive environment inducing melanoma cells dedifferentiation. While DOX influence the levels of pro-inflammatory cytokines (TNF-α and IL-6) when functional damage is caused, suggesting its successful treatment [76]. Distinctly, nanohydrogels did not instigate the elevation of TNF-α levels which confirms non-immunogenic nature.\nThe IL-6 levels (Fig. 8b) in disease and DOX as compared to normal were not crucially different. The outcome of disease control could have imputed to the attainment of an advanced stage of melanoma that has successfully evaded immune response through the resistance strategies as stated above. Indisputably, NL nanohydrogel was immunogenic as there was a significant increase in IL-6 levels in comparison with normal, disease and DOX controls. However, all other nanohydrogels were established to be non-immunogenic."
    }, {
      "heading" : "3.9. Histopathological analysis",
      "text" : "Normal control group revealed a typical lung parenchyma morphology, no abnormalities or tumor growth was observed (Fig. 9(a–b)). Disease group showed the presence of melanin in the lung parenchyma (Fig. 9(c–d)), thus distinctly showing tumor growth in the lungs. The DOX treated group showed standard lung parenchyma in compliance with a normal group that was entirely free of tumor and other abnormalities (Fig. 9(e–f)). DOX-loaded N nanohydrogels revealed standard unaffected lung parenchyma; however, a few melanomas producing colonies were observed revealing tumor growth (Fig. 9(g–h)). DOX-loaded NG nanohydrogels showed tumor affected bronchus without any lesions (Fig. 9i), while lung parenchyma appeared to be normal (Fig. 9j). DOX-loaded NL (Fig. 9(k–l)) and DOX-loaded NM\nnanohydrogels (Fig. 9(m–n)) showed normal lung parenchyma that was independent of aberrations but, a meagre number of tumor-forming colonies was distinguished. These results were by visual confirmation and metastatic lung count as shown in Fig. 9(b–c). In both histopathology and tumor count cases complete rehabilitation of lungs from melanoma was not exhibited in any of the nanohydrogels, although it was found to be notably lower than the disease group affirming its potential application as a drug carrier."
    }, {
      "heading" : "4. Conclusion",
      "text" : "The temperature sensitive PDEA nanohydrogel was successfully prepared by IEP method in a w/o emulsion. The FTIR results confirmed the polymerization of DEA by the disappearance of characteristic peaks of C]O, CeH bending and appearance of –OH, CeC peaks confirms the grafting of GQDs with PDEA nanohydrogels. The TEM analysis confirmed the size of the nanohydrogel particles which is in the range of3.56–81.11 nm. The prepared nanohydrogel had the IC50 value of 1000 μg/mL which was determined by cytotoxicity test. LCST of the synthesized nanohydrogels was determined to be around 28 °C for N, 36 °C for NG, 40 °C for NL and 32 °C for NM. Further, favorable and uniform release profile was exhibited by NG loaded with DOX at different temperature 49.59% at 30 °C, 68.15% at37 °C and 86.35% at40 °C. The drug release mechanism was studied using different models (zero-order, first-order, Higuchi, Korsmeyer-Peppas model and HixonCrowell model) and found to follow Fickian diffusion. Laterly, the synthesized nanohydrogels were used in in-vivo studies of melanoma cancer. The variations in body weight were deemed insignificant with normal control; however, all the nanohydrogels were able to depreciate splenomegaly caused by melanoma. The excellent prognosis was manifested by NG loaded with DOX as the consequence of monocytopenia, lymphocytosis and recovery of anemia towards normal blood parameters. Levels of cytokines (TNF-α andIL-6) endorsed non-immunogenic nature of all the nanohydrogels. Histopathological analysis revealed substantially normal lung parenchyma for all nanohydrogels as compared to disease control, with less visible melanin forming cells. This finding was in sync with metastatic count data which showed\nsubstantially lower count with disease control, although the tumor was not completely diminished. In the boundary of all the above study, NG loaded with DOX emerged to be the unsurpassed temperature responsive nano-drug carrier for cancer treatment.\nFunding\nThere are no funders to report for this submission.\nDeclaration of competing interest\nThe authors declare that they have no conflict of interest."
    }, {
      "heading" : "Appendix A. Supplementary data",
      "text" : "Supplementary data to this article can be found online at https:// doi.org/10.1016/j.msec.2019.110094."
    } ],
    "references" : [ {
      "title" : "Melanoma: a frequently missed diagnosis",
      "author" : [ "R. Lakhtakia", "A. Mehta", "S.K. Nema" ],
      "venue" : "Medical Journal Armed Forces India 65 ",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Late recurrence of malignant melanoma presenting with hemoptysis",
      "author" : [ "G. Karanam", "G. Vasudevan" ],
      "venue" : "Lung India 27 ",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Malignant melanoma: pattern of metastasis cancer",
      "author" : [ "N.Y.-T. Lee" ],
      "venue" : "J. Clin. Densitom. 30 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 1980
    }, {
      "title" : "Y",
      "author" : [ "Z. Yuekui", "T. Shanshan", "G. Jiamin", "A. Murad", "C. Shunxiu" ],
      "venue" : "Zhaocon, et al., Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy, Sci. Rep. 7 ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Targeted nanoparticles for cancer therapy: promises and challenges",
      "author" : [ "T.N. Kytai" ],
      "venue" : "J Nanomedic Nanotechnol 2 ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Recent advances with liposomes as pharmaceutical carriers",
      "author" : [ "V.P. Torchilin" ],
      "venue" : "Nat. Rev. Drug Discov. 4 ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Application of nanotechnology to cancer radiotherapy",
      "author" : [ "M. Yu", "S. Zhiying", "V. Johnny", "K.P. Orit", "Z.W. Andrew" ],
      "venue" : "Cancer Nano. 7 (2016) ",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Cancer nanomedicine: progress",
      "author" : [ "S. Jinjun", "W.K. Philip", "W. Richard", "C.F. Omid" ],
      "venue" : "challenges and opportunities, Nat. Rev. Cancer 17 ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Targeting strategies for the combination treatment of cancer using drug delivery systems",
      "author" : [ "K. Janel", "J. Rahul", "V. Praveena", "G. Aniket", "P. Shailee", "R. Prakash" ],
      "venue" : "Pharmaceutics 9 ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Cyclodextrin based nanogels for pharmaceutical and biomedical applications",
      "author" : [ "M.D. Moya", "C. Alvarez" ],
      "venue" : "Int. J. Pharm. 428 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Application of nanohydrogels in drug delivery systems: recent patents review",
      "author" : [ "D. Chintan", "P. Gayatri" ],
      "venue" : "Recent Patents on Nanotechnology 9 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nanocomposite polymer hydrogels",
      "author" : [ "P. Schexnailder", "G. Schmidt" ],
      "venue" : "Colloid Polym. Sci. 287 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Nanogels: an overview of properties",
      "author" : [ "S.S. Kruti", "S.D. Swapnil", "K.B. Tatiana" ],
      "venue" : "biomedical applications and obstacles to clinical translation, J. Control. Release 240 ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Role of graphene quantum dots synthesized through pyrolysis in the release behavior of temperature responsive poly (N",
      "author" : [ "H. Sushma", "P.E. JagadeeshBabu" ],
      "venue" : "Ndiethyl acrylamide) hydrogel loaded with doxorubicin, Int J Poly Anal and Char ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Nanotechnology-based drug delivery systems for melanoma antitumoral therapy: a review",
      "author" : [ "B.R. Roberta", "H.O. Márcia", "T.F. Andressa", "L.G. Maíra", "H.P. Alice", "P.D.G. Maria", "C. Marlus" ],
      "venue" : "Biomed. Res. Int. 2015 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Stimulus responsive nanogels for drug delivery",
      "author" : [ "L. Zha", "B. Banik", "F. Alexis" ],
      "venue" : "Soft Matter 7 ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "K",
      "author" : [ "H. Tajima", "S. Morimoto", "Y. Yoshida" ],
      "venue" : "Yamagiwa, Study on temperature response in raspberry-form gels of poly (N,N-diethylacrylamide), Polymer Science Series A 54 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Photopolymerised thermo-responsive poly (N",
      "author" : [ "J.I. Ngadaonye", "L.M. Geever", "M.O. Cloonan", "C.L. Higginbotham" ],
      "venue" : "N-diethylacrylamide)-based copolymer hydrogels for potential drug delivery applications, J. Polym. Res. 19 ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "J",
      "author" : [ "J.I. Ngadaonye", "L.M. Geever" ],
      "venue" : "Killion, C.L. Higginbotham, Development of novel chitosan-poly(N,N-diethylacrylamide) IPN films for potential wound dressing and biomedical applications, J. Polym. Res. 20 ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chinese quince seed gum and poly (N",
      "author" : [ "A.J. Xie", "H.S. Yin", "H.M. Liu", "C.Y. Zhu", "Y.J. Yang" ],
      "venue" : "N-diethylacryl amide-co-methacrylic acid) based pH-sensitive hydrogel for use in drug delivery, Carbohydr. Polym. 185 ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Development of thermo/pH-responsive chitosan coated pectin-graft-poly(N",
      "author" : [ "N. Işıklan", "Ş. Tokmak" ],
      "venue" : "N-diethyl acrylamide) microcarriers, Carbohydr. Polym. 218 ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2019
    }, {
      "title" : "Z",
      "author" : [ "N. Isiklan" ],
      "venue" : "Altınısik, Development and characterization of dual sensitive poly (N,N-diethyl acrylamide) grafted alginate microparticles, Colloids Surf. A Physicochem. Eng. Asp. ",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2019
    }, {
      "title" : "H",
      "author" : [ "X. Wu", "X. Bai", "Y. Ma", "J. Wei", "J. Peng", "K. Shi" ],
      "venue" : "Yao, Construction of multiple switchable sensors and logic gates based on carboxylated multi-walled carbon nanotubes/poly(N,N-diethylacrylamide), Sensors 18 ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "M",
      "author" : [ "Y. Xu", "J. Guo", "D. Chen", "L. Cao" ],
      "venue" : "Dong, Synthesis and thermothickening behavior of graft copolymers based on poly (N,N-diethylacrylamide-co-N,N-dimethylacrylamide) side chains, Polym.-Plast. Technol. Eng. 57 ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Nanogels of poly-N-isopropylacrylamide",
      "author" : [ "Y. Zhao", "W. Sun", "M.D.A. Saldaña" ],
      "venue" : "poly- N,N-diethylacrylamide and acrylic acid for controlled release of thymol, J. Polym. Res. 25 ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Photopolymerisation and characterization of negative temperature sensitive hydrogels based on N",
      "author" : [ "M.G. Luke", "G.L. John", "L.H. Clement" ],
      "venue" : "N-diethyl acrylamide, J. Mater. Sci. 46 ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "pH/temperature double responsive behaviors and mechanical strength of laponite-crosslinked poly(DEA-co- DMAEMA) nanocomposite hydrogels",
      "author" : [ "H. Li", "R. Wu", "J. Zhu", "P. Guo", "W. Ren", "S. Xu", "J. Wang" ],
      "venue" : "J. Polymer Sci., Part B: Polymer Phys. 53 ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "T",
      "author" : [ "N. Mpho", "E.C. Yahya" ],
      "venue" : "Charu, K.T. Lomas, et al., Integration of biosensors and drug delivery technologies for early detection and chronic management of illness, Sensors 13 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Structure observation of graphene quantum dots by single-layered formation in layered confinement space",
      "author" : [ "L. Song", "J. Shi", "J. Lu", "C. Lu" ],
      "venue" : "Chem. Sci. 6 ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Graphene quantum dots: effect of size",
      "author" : [ "P. Elvati", "E. Baumeister", "A. Violi" ],
      "venue" : "composition and curvature on their assembly, RSC Adv. 7 ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Application of graphene quantum dots for simultaneous fluorescence imaging and tumor-targeted drug delivery",
      "author" : [ "J. Dong", "K. Wang", "L. Sun", "B. Sun", "M. Yang", "H. Chen", "Y. Wang", "J. Sun", "L. Dong" ],
      "venue" : "Sensors Actuators B Chem. 256 ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Acid-free and oxone oxidant-assisted solvothermal synthesis of graphene quantum dots using various natural carbon materials as resources",
      "author" : [ "Y. Shin", "J. Park", "D. Hyun", "J. Yang", "J.H. Lee", "J.H. Kim", "H. Lee" ],
      "venue" : "Nanoscale 7 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Gram-scale synthesis of high-purity graphene quantum dots with multicolor photoluminescence",
      "author" : [ "F. Liu", "Y. Sun", "Y. Zheng", "N. Tang", "M. Li", "W. Zhong", "Y. Du" ],
      "venue" : "RSC Adv. 5 ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Glowing graphene quantum dots and carbon dots: properties",
      "author" : [ "X.T. Zheng", "A. Ananthanarayanan", "K.Q. Luo", "P. Chen" ],
      "venue" : "syntheses, and biological applications, Small 11 ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Pietro",
      "author" : [ "D. Iannazzo", "A. Pistone", "M. Salamò", "S. Galvagno", "R. Romeo", "S.V. Giofré", "C. Branca", "G. Visalli", "A. Di" ],
      "venue" : "Graphene quantum dots for cancer targeted drug delivery, Int. J. Pharm. 518 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "N",
      "author" : [ "D. Suvakanta", "P.M. Narasimha" ],
      "venue" : "lilakanta, C. Prasanta, Kinetic modeling on drug release from controlled drug delivery systems, Actapoloniae Pharmaceutica-Drug Research 67 ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Fabrication and characterization of a novel anticancer drug delivery system: salecan/poly(methacrylic acid) semi-interpenetrating polymer network hydrogel",
      "author" : [ "Q. Xiaoliang", "W. Wei", "L. Junjian", "L. Yucheng", "H. Xinyu", "Z. Jianfa", "B. Lirong", "D. Wei" ],
      "venue" : "ACS Biomater Sci Eng 1 ",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary  carcinoma in rodent models",
      "author" : [ "L. Mingqiang", "T. Zhaohui", "Z. Dawei", "S. Hai", "L. Huaiyu", "Z. Ying", "Z. Yuanyuan", "C. Xuesi" ],
      "venue" : "Biomaterials 51 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models",
      "author" : [ "S.B. Swapnil", "M.R. Srikumar", "O.K. Jong", "M. Bhopal", "S.S. Kruti", "L. Haitao", "H.W. Stetson", "A.B. Timoth", "F. Dan", "S. Matthew", "B. Vimla", "M.C. Samuel", "B. Hamid", "K.B. Tatiana" ],
      "venue" : "J. Control. Release 208 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Formation mechanism and optimization of highly luminescent N-doped graphene quantum dots",
      "author" : [ "D. Qu", "M. Zheng", "L. Zhang", "H. Zhao", "Z. Xie", "X. Jing", "R.E. Haddad", "H. Fan", "Z. Sun" ],
      "venue" : "Sci. Rep. 4 ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Recent advances in the fabrication and structure-specific applications of graphene-based inorganic hybrid membranes",
      "author" : [ "X. Zhao", "P. Zhang", "Y. Chen", "Z. Su", "G. Wei" ],
      "venue" : "Nanoscale 7 ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "A general quantitative pH sensor developed with dicyandiamide N-doped high quantum yield graphene quantum dots",
      "author" : [ "Z.L. Wu", "M.X. Gao", "T.T. Wang", "X.Y. Wan", "L.L. Zhenga", "C.Z. Huang" ],
      "venue" : "Nanoscale 6 ",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Non-covalent decoration of carbon dots with folic acid via a polymer-assisted strategy for fast and targeted cancer cell fluorescence imaging",
      "author" : [ "D. Lei", "W. Yang", "Y. Gong", "J. Jing", "H. Nie", "B. Yu", "X. Zhang" ],
      "venue" : "Sensors Actuators B Chem. 230 ",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "D-penicillaminefunctionalized graphene quantum dots for fluorescent detection of Fe in iron supplement oral liquids",
      "author" : [ "W. Xuan", "L. Ruiyi", "F. Saiying", "L. Zaijun", "W. Guangli", "G. Zhiguo" ],
      "venue" : "Sensors Actuators B Chem. 243 ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Easy synthesis of highly fluorescent carbon quantum dots from gelatin and their luminescent properties and applications",
      "author" : [ "Q. Liang", "W. Ma", "Y. Shi", "Z. Li", "X. Yang" ],
      "venue" : "Carbon 60 ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "An efficient and stable fluorescent graphene quantum dot–agar composite as a converting material in white light emitting diodes",
      "author" : [ "C.M. Luk", "L.B. Tang", "W.F. Zhang", "S.F. Yu", "K.S. Teng", "S.P. Lau" ],
      "venue" : "J. Mater. Chem. 22 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Nitrogen-doped graphene quantum dots-based fluorescent probe for the sensitive turn-on detection of glutathione and its cellular imaging",
      "author" : [ "J. Ju", "R. Zhang", "S. He", "W. Chen" ],
      "venue" : "RSC Adv. 4 ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Enhanced photoluminescence of pyrrolicnitrogen enriched graphene quantum dots",
      "author" : [ "Y.N. Hao", "H.L. Guo", "L. Tian", "X. Kang" ],
      "venue" : "RSC Adv. 5 ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Blue luminescent graphene quantum dots and graphene oxide prepared by tuning the carbonization degree of citric acid",
      "author" : [ "Y. Dong", "J. Shao", "C. Chen", "H. Li", "R. Wang", "Y. Chi", "X. Lin", "G. Chen" ],
      "venue" : "Carbon 50 ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Rapid synthesis of carbon dots by hydrothermal treatment of lignin",
      "author" : [ "C. Wenxin", "H. Chaofan", "Y. Yunhua", "C. Jianghu", "L. Yingliang" ],
      "venue" : "Materials 9 ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "A label-free electrochemical platform for the highly sensitive detection of hepatitis B virus DNA using graphene quantum dots",
      "author" : [ "X. Qian", "H. Jingyun", "H. Huiyao", "W.M. Wei", "Y. Zhizhen" ],
      "venue" : "RSC Adv. 8 ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Spotlighting graphene quantum dots and beyond: synthesis",
      "author" : [ "M.O. Valappil", "V.K. Pillai", "S. Alwarappan" ],
      "venue" : "properties and sensing applications, Appl. Mater. Today 9 ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Synthesis and characterisation of thermo responsive poly(N",
      "author" : [ "M. Panayiotou", "C. Pöhner", "C. Vandevyver", "C. Wandrey", "F. Hilbrig", "R. Freitag" ],
      "venue" : "N-diethyl acrylamide) microgels, React. Funct. Polym. 67 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Preparation and in vitro evaluation of isoniazid-containing Dex-HEMA-Co-PNIPAAm nanogels",
      "author" : [ "M. Jafari", "B. Kaffashi" ],
      "venue" : "Ciência E Nat 37 ",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Inhibition of metastasis of B16F10 melanoma cells in C57BL/6 mice by an extract of Calendula officinalis L flowers",
      "author" : [ "K.C. Preethi", "K.S. Siveen", "R. Kuttan", "G. Kuttan" ],
      "venue" : "Asian Pac. J. Cancer Prev. 11 ",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Role of N-vinyl-2-pyrrolidinone on the thermoresponsive behavior of PNIPAm hydrogel and its release kinetics using dye and vitamin-B12 as a model drug",
      "author" : [ "B. Maheswari", "P.E. JagadeeshBabu", "M. Agarwal" ],
      "venue" : "Aust. J. Biol. Sci. 25 ",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "pH/thermo-responsive poly (N-isopropylacrylamide-co-maleic acid) hydrogel with a sensor and an actuator for biomedical applications",
      "author" : [ "G. Fundueanu", "M. Constantin", "S. Bucatariu", "P. Ascenzi" ],
      "venue" : "Polymer (Guildf) 110 ",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Conformation–function relationships for the comb-shaped polymer pOEGMA",
      "author" : [ "M. Liu", "J.C. Leroux", "M.A. Gauthier" ],
      "venue" : "Prog. Polym. Sci. 48 ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy",
      "author" : [ "F. Kou", "Z. Lu", "J. Li", "X. Zhang", "M. Lu", "J. Zhou", "X. Wang", "J. Gong", "J. Gao", "J. Li" ],
      "venue" : "Cancer Med 5 ",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery",
      "author" : [ "X. Yao", "X. Niu", "K. Ma", "P. Huang", "J. Grothe", "S. Kaskel", "Y. Zhu" ],
      "venue" : "magnetic hyperthermia, and photothermal therapy, Small 13 ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots",
      "author" : [ "C. Wang", "C. Wu", "X. Zhou", "T. Han", "X. Xin", "J. Wu", "J. Zhang", "S. Guo" ],
      "venue" : "Sci. Rep. 3 ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Graphene quantum dots enhance anticancer activity of cisplatin via increasing its cellular and nuclear uptake",
      "author" : [ "X. Sui", "C. Luo", "C. Wang", "F. Zhang", "J. Zhang", "S. Guo" ],
      "venue" : "nanomedicine: nanotechnology, Biol. & Med. 12 ",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Experimental measures of amino acid hydrophobicity and the topology of transmembrane and globular proteins",
      "author" : [ "R. Wolfenden" ],
      "venue" : "J. Gen. Physiol. 129 ",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Triple cell-responsive nanogels for delivery of drug into cancer cells",
      "author" : [ "X. Xu", "X. Wang", "W. Luo", "Q. Qian", "Q. Li", "B. Han", "Y. Li" ],
      "venue" : "Colloids Surf. B. Biointerfaces. 163 ",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Effect of demethoxycurcumin on biochemical markers",
      "author" : [ "S.S. Agrawal", "S. Gullaiya", "V. Dubey", "A. Nagar", "A. Kumar", "P. Nagar", "V. Singh" ],
      "venue" : "oxidative stress and histopathological alterations in anthracyclines cardiotoxicity rat model, J. Pharm. Res. 5 ",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Melanoma induced immunosuppression is mediated by hematopoietic dysregulation",
      "author" : [ "N. Kamran", "Y. Li", "M. Sierra", "M.S. Algahmri", "P. Kadiyala", "H.D. Appelman", "M. Edwards", "P.R. Lowenstein", "M.G. Castro" ],
      "venue" : "Oncoimmunology 7 (2018) e1408750.  S. Havanur, et al. Materials Science & Engineering C 105 ",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2019
    }, {
      "title" : "Effect of spleen lymphocytes on the splenomegaly in hepatocellular carcinoma-bearing mice",
      "author" : [ "J.J. Fang", "Z.Y. Zhu", "D. Hui", "G.Q. Zheng", "A.G. Teng", "A.J. Liu" ],
      "venue" : "Biomed. Environ. Sci. 27 ",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "A cellbased drug delivery system for lung targeting: II",
      "author" : [ "S. Jun", "D. Jean", "L. Donald", "N.W. David", "J.M. Carl", "R. Yongyut", "K.H.M. Joseph" ],
      "venue" : "Therapeutic activities on B16-F10 melanoma in mouse lungs, Drug Delivery 8 ",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "The role of complete blood cell count in prognosis-watch this space",
      "author" : [ "N.M. Rochet", "S.N. Markovic", "L.F. Porrata" ],
      "venue" : "Oncol Hematol Rev 8 ",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Mouse models of anemia of cancer",
      "author" : [ "A. Kim", "S. Rivera", "D. Shprung", "D. Limbrick", "V. Gabayan", "E. Nemeth", "T. Ganz" ],
      "venue" : "PLoS One 9 ",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Platelets at the interface of thrombosis",
      "author" : [ "A.T. Franco", "A. Corken", "J. Ware" ],
      "venue" : "inflammation, and cancer, Blood 126 ",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Prognostic value of chemotherapy-induced leukopenia in small-cell lung cancer",
      "author" : [ "W. Liu", "C.C. Zhang", "K. Li" ],
      "venue" : "Cancer Biol. Med. 10 ",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model",
      "author" : [ "V.G. Desai", "E.H. Herman", "C.L. Moland", "W.S. Branham", "S.M. Lewis", "K.J. Davis", "N.I. George", "T. Lee", "S. Kerr", "J.C. Fuscoe" ],
      "venue" : "Toxicol. Appl. Pharmacol. 266 ",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Paradoxical roles of tumour necrosis factoralpha in prostate cancer biology",
      "author" : [ "W.C.T. Brian", "F.S. Kieran", "J.R. Pamela" ],
      "venue" : "Prostate Cancer 2012 ",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity",
      "author" : [ "M. Pecoraro", "M.D. Pizzo", "S. Marzocco", "R. Sorrentino", "M. Ciccarelli", "G. Iaccarino", "A. Pinto", "A. Popolo" ],
      "venue" : "Toxicol. Appl. Pharmacol. 293 (2016) 44–52.  S. Havanur, et al. Materials Science & Engineering C 105 ",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2019
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Recent statistics of the World Health Organization has reported that approximately 132,000 new cases of melanoma are diagnosed worldwide each year, especially among western countries, for example, in the United States the percentage of people affected by melanoma has more than doubled in the past 30 years [1,2].",
      "startOffset" : 307,
      "endOffset" : 312
    }, {
      "referenceID" : 1,
      "context" : "Recent statistics of the World Health Organization has reported that approximately 132,000 new cases of melanoma are diagnosed worldwide each year, especially among western countries, for example, in the United States the percentage of people affected by melanoma has more than doubled in the past 30 years [1,2].",
      "startOffset" : 307,
      "endOffset" : 312
    }, {
      "referenceID" : 2,
      "context" : "The prime cause of mortality (about 39%) in lung metastasis is respiratory failure, which is due to the replacement of normal lung tissue by tumor cells [3].",
      "startOffset" : 153,
      "endOffset" : 156
    }, {
      "referenceID" : 3,
      "context" : "Respiratory failure is generally due to resistance to the drug, low targeting efficiency and lack of target selectivity between tumor cells and normal cells [4].",
      "startOffset" : 157,
      "endOffset" : 160
    }, {
      "referenceID" : 4,
      "context" : "Non-specific delivery of drugs become toxic to normal cells, tissues, organs and limits the therapeutic dose within cancer cells; and further causes several adverse side effects including hair loss, weakness, and organ dysfunction [5].",
      "startOffset" : 231,
      "endOffset" : 234
    }, {
      "referenceID" : 4,
      "context" : "Kytai (2011) and Torchilin (2014) has classified the NDDs as follows: lipid-based vehicles (micelles, solid lipid nanoparticles, and liposomes), polymeric carriers (hydrogels, polymersomes, dendrimers, and nanofibers), carbon structures (nanodiamonds, nanotubes, graphene, and nanohorns), metallic nanoparticles (gold, silver, and titanium), and inorganic particles (silica) [5,6].",
      "startOffset" : 375,
      "endOffset" : 380
    }, {
      "referenceID" : 5,
      "context" : "Kytai (2011) and Torchilin (2014) has classified the NDDs as follows: lipid-based vehicles (micelles, solid lipid nanoparticles, and liposomes), polymeric carriers (hydrogels, polymersomes, dendrimers, and nanofibers), carbon structures (nanodiamonds, nanotubes, graphene, and nanohorns), metallic nanoparticles (gold, silver, and titanium), and inorganic particles (silica) [5,6].",
      "startOffset" : 375,
      "endOffset" : 380
    }, {
      "referenceID" : 9,
      "context" : "Among the available NDDs, polymeric nanohydrogels have gained enough attention due to their extensive flexibility, simple preparation and effective drug encapsulation (high/low molecular weights, hydrophilic/hydrophobic molecules, and biopharmaceuticals) [11].",
      "startOffset" : 255,
      "endOffset" : 259
    }, {
      "referenceID" : 10,
      "context" : "Nanohydrogels are 3D polymeric network cross-linked with hydrophilic macro-molecules with a diameter of 1–100 nm [12].",
      "startOffset" : 113,
      "endOffset" : 117
    }, {
      "referenceID" : 11,
      "context" : "These nanohydrogels have characteristics features of both hydrogels and nanoparticles like hydrophilicity, flexibility, versatility, high water absorptivity and biocompatibility along with all the merits of nanoparticles [13].",
      "startOffset" : 221,
      "endOffset" : 225
    }, {
      "referenceID" : 12,
      "context" : "Nanohydrogels change their network structure, chemical properties, swelling/deswelling property, and permeability in response to external environmental parameters such as temperature, pH, solvent composition, electric field, and ionic strength and these hydrogels are called as stimuli-responsive nanohydrogels [14,15].",
      "startOffset" : 311,
      "endOffset" : 318
    }, {
      "referenceID" : 13,
      "context" : "Nanohydrogels change their network structure, chemical properties, swelling/deswelling property, and permeability in response to external environmental parameters such as temperature, pH, solvent composition, electric field, and ionic strength and these hydrogels are called as stimuli-responsive nanohydrogels [14,15].",
      "startOffset" : 311,
      "endOffset" : 318
    }, {
      "referenceID" : 14,
      "context" : "In melanoma therapy, nanohydrogels can act as an intratumoral chemotherapeutic agent by promoting accumulation or maintenance of high levels of an intracellular chemotherapeutic agent [16].",
      "startOffset" : 184,
      "endOffset" : 188
    }, {
      "referenceID" : 15,
      "context" : "Thermo-responsive nanohydrogels undergo a volume phase transition along with a change in particle size based on upper or lower critical solution temperature (UCST or LCST) [17].",
      "startOffset" : 172,
      "endOffset" : 176
    }, {
      "referenceID" : 25,
      "context" : "Researchers have tried to change the LCST of PDEA (Table 1 [21–26]) using different monomers like DMAAm, NVP [27] and clay particles [28], but they could not retain or improve mechanical strength, release characteristics, in vitro, and invivo biocompatibility of native PDEA.",
      "startOffset" : 109,
      "endOffset" : 113
    }, {
      "referenceID" : 26,
      "context" : "Researchers have tried to change the LCST of PDEA (Table 1 [21–26]) using different monomers like DMAAm, NVP [27] and clay particles [28], but they could not retain or improve mechanical strength, release characteristics, in vitro, and invivo biocompatibility of native PDEA.",
      "startOffset" : 133,
      "endOffset" : 137
    }, {
      "referenceID" : 27,
      "context" : "Table 2 shows the advantages and disadvantages of different nanosystem used as drug delivery carriers [29].",
      "startOffset" : 102,
      "endOffset" : 106
    }, {
      "referenceID" : 28,
      "context" : "Graphene sheets with lateral dimensions< 100 nm in few layers (< 10 layers) form a novel group of molecules called graphene quantum dots (GQDs) [30,31].",
      "startOffset" : 144,
      "endOffset" : 151
    }, {
      "referenceID" : 29,
      "context" : "Graphene sheets with lateral dimensions< 100 nm in few layers (< 10 layers) form a novel group of molecules called graphene quantum dots (GQDs) [30,31].",
      "startOffset" : 144,
      "endOffset" : 151
    }, {
      "referenceID" : 30,
      "context" : "GQDs can be used in drug delivery system due to the presence of various functional groups like carboxyl, hydroxyl, carbonyl, and epoxy groups and also has significant delocalized π electrons [32].",
      "startOffset" : 191,
      "endOffset" : 195
    }, {
      "referenceID" : 31,
      "context" : "GQDs emerged as superior and universal fluorophores because of their unique physical and chemical properties, including small size, chemical inertness, stable photoluminescence (PL), low cytotoxicity, and excellent biocompatibility [33,34].",
      "startOffset" : 232,
      "endOffset" : 239
    }, {
      "referenceID" : 32,
      "context" : "GQDs emerged as superior and universal fluorophores because of their unique physical and chemical properties, including small size, chemical inertness, stable photoluminescence (PL), low cytotoxicity, and excellent biocompatibility [33,34].",
      "startOffset" : 232,
      "endOffset" : 239
    }, {
      "referenceID" : 33,
      "context" : "Due to their stable PL and low cytotoxicity, GQDs could be utilized as suitable alternatives in bio-imaging and optical sensing [35].",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 34,
      "context" : "and its biocompatibility, GQDs could also serve as active carriers for drug delivery while simultaneously monitoring the release of the drug, to enhance the chemotherapeutic efficiency of anticancer drugs and can improve the performance of drug carrier [36].",
      "startOffset" : 253,
      "endOffset" : 257
    }, {
      "referenceID" : 13,
      "context" : "GQDs were synthesized by microwave-assisted pyrolysis of CA [15].",
      "startOffset" : 60,
      "endOffset" : 64
    }, {
      "referenceID" : 25,
      "context" : "Advantages and disadvantages of different nanosystem used as drug delivery carriers [27].",
      "startOffset" : 84,
      "endOffset" : 88
    }, {
      "referenceID" : 35,
      "context" : "Following equations are the model equations used to analyze drug release mechanism [37,38].",
      "startOffset" : 83,
      "endOffset" : 90
    }, {
      "referenceID" : 36,
      "context" : "Following equations are the model equations used to analyze drug release mechanism [37,38].",
      "startOffset" : 83,
      "endOffset" : 90
    }, {
      "referenceID" : 37,
      "context" : "Injected nanohydrogel concentration was established according to their encapsulation efficiency as reported in the literature [39,40], homologous to 2.",
      "startOffset" : 126,
      "endOffset" : 133
    }, {
      "referenceID" : 38,
      "context" : "Injected nanohydrogel concentration was established according to their encapsulation efficiency as reported in the literature [39,40], homologous to 2.",
      "startOffset" : 126,
      "endOffset" : 133
    }, {
      "referenceID" : 39,
      "context" : "CA molecules selfassembled into thin sheet-like structure followed by condensation reactions through intermolecular dehydroxylation, forming nanocrystalline GQDs with functional groups like-OH, -CH2-, -COOH, -COOR on its surface [41,42].",
      "startOffset" : 229,
      "endOffset" : 236
    }, {
      "referenceID" : 40,
      "context" : "CA molecules selfassembled into thin sheet-like structure followed by condensation reactions through intermolecular dehydroxylation, forming nanocrystalline GQDs with functional groups like-OH, -CH2-, -COOH, -COOR on its surface [41,42].",
      "startOffset" : 229,
      "endOffset" : 236
    }, {
      "referenceID" : 41,
      "context" : "During the synthesis process, the –NH2 group of Leu and Met reacts with carboxyl or hydroxyl groups of the GQDs to form leucine functionalized GQDs and methionine functionalized GQDs [43].",
      "startOffset" : 183,
      "endOffset" : 187
    }, {
      "referenceID" : 44,
      "context" : "1b were recorded at 365 nm, and the bare GQDs shows a sharp peak at 450 nm, leucine functionalized GQDs at 457 nm and methionine functionalized GQDs at 490 nm [46].",
      "startOffset" : 159,
      "endOffset" : 163
    }, {
      "referenceID" : 45,
      "context" : "the literature for carbon-based quantum dots [47,48].",
      "startOffset" : 45,
      "endOffset" : 52
    }, {
      "referenceID" : 46,
      "context" : "the literature for carbon-based quantum dots [47,48].",
      "startOffset" : 45,
      "endOffset" : 52
    }, {
      "referenceID" : 47,
      "context" : "In this study, the enhanced PL was attributed to the formation of pyrrolic-N in GQDs, which substituted the –COOH functional groups at the edges of GQDs and also the relatively strong electron affinity of pyrrolic-N rings in the leucine functionalized GQDs and methionine functionalized GQDs [49].",
      "startOffset" : 292,
      "endOffset" : 296
    }, {
      "referenceID" : 51,
      "context" : "GQDs, leucine functionalized GQDs and methionine functionalized GQDs contain epoxy and carboxylic groups on their surface it acted as non-radiative electron-hole recombination centre [53].",
      "startOffset" : 183,
      "endOffset" : 187
    }, {
      "referenceID" : 52,
      "context" : "The particle size distribution of prepared nanohydrogels are shown in Table 3, and from the table it could be observed that the particle size varied significantly which could be due to a premature termination of particle growth, which is caused by the presence of the oxygen in the reaction mixture [54].",
      "startOffset" : 299,
      "endOffset" : 303
    }, {
      "referenceID" : 52,
      "context" : "Further, the irradiation of electron beam under reduced pressure may swell or shrink, and also the surface tension causes the agglomeration of particles [54].",
      "startOffset" : 153,
      "endOffset" : 157
    }, {
      "referenceID" : 53,
      "context" : "Degradation could be ascribed to the presence of hydrolytic groups like ester, amine which break down easily by water [55].",
      "startOffset" : 118,
      "endOffset" : 122
    }, {
      "referenceID" : 54,
      "context" : "This could be explained by a nonanalogous dispensation of the drug inside a nanohydrogel structure [56].",
      "startOffset" : 99,
      "endOffset" : 103
    }, {
      "referenceID" : 55,
      "context" : "The hydrophilic-nature of hydrogel could be the reason for poor response rate below LCST [57].",
      "startOffset" : 89,
      "endOffset" : 93
    }, {
      "referenceID" : 56,
      "context" : "Below LCST, the polymer is hydrated but once LCST is exceeded, polymeric chains disintegrate and aggregate abruptly and thus, nanohydrogel shrinks drastically [58].",
      "startOffset" : 159,
      "endOffset" : 163
    }, {
      "referenceID" : 57,
      "context" : "This phenomenon can be attributed to the incorporation of hydrophilic GQDs moieties [59,60].",
      "startOffset" : 84,
      "endOffset" : 91
    }, {
      "referenceID" : 58,
      "context" : "This phenomenon can be attributed to the incorporation of hydrophilic GQDs moieties [59,60].",
      "startOffset" : 84,
      "endOffset" : 91
    }, {
      "referenceID" : 59,
      "context" : "Higher temperature (40 °C) can weaken the chemical bond strength between the polymeric matrix and GQDs resulting in its dissociation and accelerating DOX release [61].",
      "startOffset" : 162,
      "endOffset" : 166
    }, {
      "referenceID" : 60,
      "context" : "Dissociation of GQDs is beneficial as it possesses anticancer properties and is also able to enhance the activity of DOX [62,63].",
      "startOffset" : 121,
      "endOffset" : 128
    }, {
      "referenceID" : 61,
      "context" : "Dissociation of GQDs is beneficial as it possesses anticancer properties and is also able to enhance the activity of DOX [62,63].",
      "startOffset" : 121,
      "endOffset" : 128
    }, {
      "referenceID" : 62,
      "context" : "The reason for these phenomena is the hydrophobic nature of methionine that lowers the LCST of nanohydrogel favoring non-uniform burst release profile [64].",
      "startOffset" : 151,
      "endOffset" : 155
    }, {
      "referenceID" : 57,
      "context" : "The NG, NL and NM showed a controlled and uniform release than N due to the change in their LCST [59].",
      "startOffset" : 97,
      "endOffset" : 101
    }, {
      "referenceID" : 63,
      "context" : "As the experiment progressed, the release profiles were accompanied by absorption and desorption of the drug, which was due to re-absorption of DOX and induced precipitation in PBS buffer and degradation of free DOX via hydrolysis [65].",
      "startOffset" : 231,
      "endOffset" : 235
    }, {
      "referenceID" : 64,
      "context" : "DOX group showed significant hepatomegaly, but effect of DOX was reduced by the DOX-loaded nanohydrogels [66].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 65,
      "context" : "Splenomegaly as the hallmark of melanoma had been reported in literature [67].",
      "startOffset" : 73,
      "endOffset" : 77
    }, {
      "referenceID" : 66,
      "context" : "Enlarging of the spleen can be explicated to confinement of T lymphocytes in the spleen during lymphocyte recirculation [68].",
      "startOffset" : 120,
      "endOffset" : 124
    }, {
      "referenceID" : 67,
      "context" : "A pronounced reduction of tumor count was observed in DOX-loaded N and NG groups in analogy with the disease group [69].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 68,
      "context" : "The hematological framework is contemplated as a principle indicator of cancer development and prognostic factor for the positive or negative outcome [70].",
      "startOffset" : 150,
      "endOffset" : 154
    }, {
      "referenceID" : 69,
      "context" : "The above anomalies demonstrate poorer prognosis in diseased group which was administered with PBS buffer alone [71].",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 59,
      "context" : "Foundation of lymphopenia in melanoma is not well illuminated, but one of the reasons could be uninterrupted apoptosis of T lymphocyte caused by tumors [61].",
      "startOffset" : 152,
      "endOffset" : 156
    }, {
      "referenceID" : 69,
      "context" : "The anemic disorder can be attributed to many factors, like insufficiency of iron, hemolysis, damaged erythropoiesis, tumor cell annexation in erythropoietic environment and initiation of clotting torrent [71].",
      "startOffset" : 205,
      "endOffset" : 209
    }, {
      "referenceID" : 70,
      "context" : "Stimulation of platelets facilitates cell attachment, multiplication and chemotaxins, in turn promote tumorigenesis [72].",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 71,
      "context" : "Leukopenia is a biological measurement of drug activity associated with the hematologic toxicity caused by drugs to predict the efficiency of treatment [73].",
      "startOffset" : 152,
      "endOffset" : 156
    }, {
      "referenceID" : 72,
      "context" : "Anemic conditions depicted by the disease model were recovered, but it is significantly different than normal (PBS injected) conditions, similar results were observed in the literature [74].",
      "startOffset" : 185,
      "endOffset" : 189
    }, {
      "referenceID" : 68,
      "context" : "The condition of monocytopenia and differentiation of myeloid progenitors was reduced which signifies an improvement in tumor conditions, and additionally it is a positive prognostic factor [70].",
      "startOffset" : 190,
      "endOffset" : 194
    }, {
      "referenceID" : 68,
      "context" : "t disease group, all conditions favoring better survival rate [70].",
      "startOffset" : 62,
      "endOffset" : 66
    }, {
      "referenceID" : 73,
      "context" : "They can facilitate the generation and maintenance of robust antitumor immune responses, but they can also contribute to chronic inflammation and promote tumor formation, growth and metastasis [75].",
      "startOffset" : 193,
      "endOffset" : 197
    }, {
      "referenceID" : 74,
      "context" : "While DOX influence the levels of pro-inflammatory cytokines (TNF-α and IL-6) when functional damage is caused, suggesting its successful treatment [76].",
      "startOffset" : 148,
      "endOffset" : 152
    } ],
    "year" : 2019,
    "abstractText" : "Cancer has emanated as a daunting menace to human-kind even though medicine, science, and technology has reached its zenith. Subsequent scarcity in the revelation of new drugs, the exigency of salvaging formerly discovered toxic drugs such as doxorubicin has emerged. The invention of drug carrier has made drug delivery imminent which is ascribable to its characteristic traits of specific targeting, effective response to stimuli and biocompatibility. In this paper, the nanoscale polymeric drug carrier poly(N,N-diethyl acrylamide) nanohydrogel has been synthesized by inverse emulsion polymerization. Lower critical solution temperature of the polymeric carrier has been modified using graphene quantum. The particle size of pure nanohydrogel was in the range of 47 to 59.5 nm, and graphene quantum dots incorporated nanohydrogels was in the range of 68.1 to 87.5 nm. Doxorubicin (hydroxyl derivative of anthracycline) release behavior as a function of time and temperature was analyzed, and the Lower critical solution temperature of the synthesized nanohydrogels has been found to be in the range of 28–42 °C. Doxorubicin release characteristics have improved significantly as the surrounding temperature of the release media was increased near to physiological temperature. Further, the cumulative release profile was fitted in the different kinetic model and found to follow a Fickian diffusion release mechanism. The hydrogel was assessed for its cytotoxicity in B16F10 cells by MTT assay. In-vivo studies were done to study the lung metastasis by melanoma cancer and the results showed a rational favorable prognosis which was confirmed by evaluating hematological parameters and the non-immunogenic nature of nanohydrogel by cytokine assay. Comprehensively, the results suggested that poly(N,N-diethyl acrylamide) nanohydrogels have potential application as an intelligent drug carrier for melanoma cancer.",
    "creator" : "Elsevier"
  }
}